Developer docs
API playgroundTry for free, no card

Search company profiles

Promefarma

Full company profile

uuid002y94e

Namestring
Promefarma
Legal namestring
Promefarma
Company typeenum
Private
Founded yearint
1989
Descriptiontext

Promefarma Produtos Farmacêuticos is a privately held Brazilian pharmaceutical distributor founded on December 12, 1989, and headquartered in Curitiba, Paraná. The company distributes a comprehensive medication portfolio—including analgesics, controlled substances, high-cost drugs, oncology products, biosimilars, injectables, and thrombolytics—to public and private healthcare institutions across at least eight Brazilian states (Paraná, Santa Catarina, Rio Grande do Sul, São Paulo, Rio de Janeiro, Minas Gerais, Mato Grosso, and Espírito Santo). Its go-to-market is sales-led and bifurcated: a dedicated public sector team handles licitações (public bidding processes) across federal, state, and municipal levels, while a separate direct sales force with supervisor accompaniment serves private hospitals, clinics, and home care providers. The company maintains roughly 100+ direct employees and serves 5,626+ active clients. Revenue is generated through transaction-fee-based medication distribution plus consulting services for product demonstrations and standardization visits. The business is founder-led by the Barotto brothers and currently directed by Élcio and Luciana, with no external investors or parent company involvement disclosed. Operational governance is supported by a compliance channel, ouvidoria, and SAC infrastructure, and the company has pursued ESG credentials—achieving the highest Selo Clima Paraná A certification in 2025—and received multiple governmental recognitions (ALEP "Paranaenses em Destaque" in 2026, Câmara Municipal de Curitiba congratulations in 2025). In early 2026, Promefarma reported a record historical monthly billing milestone for March.

Short descriptiontext

Promefarma is a privately held Brazilian pharmaceutical distributor founded in 1989, headquartered in Curitiba, serving 5,626+ public and private healthcare institutions across 8 Brazilian states with a comprehensive medication portfolio through public bidding and direct sales channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCuritiba, Brazil
HQ citystring
Curitiba
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, medication distribution, healthcare procurement services, public bidding services, hospital medication supply
Industry1 code
1Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
CodeHLAIAJAFPrimaryYes
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Distribution
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medication Distribution - Public Sector
TypeTransaction Fee
Description

Distribution of medications to government healthcare facilities through public bidding processes (licitações). The company has specialized professionals for all stages of bidding processes.

promefarma.com.br
2Medication Distribution - Private Sector
TypeTransaction Fee
Description

Direct sales of medications to private hospitals, clinics, and home care institutions. Includes personalized negotiation and direct delivery.

promefarma.com.br
3Direct Sales and Consulting
TypeProfessional Services
Description

Consulting services for product demonstrations and standardization for healthcare institutions

promefarma.com.br
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Promefarma is a Brazilian pharmaceutical distributor headquartered in Curitiba, Paraná, that supplies a full line of medications—including controlled substances and high-cost drugs—to public and private healthcare institutions. The company operates three principal service lines: Venda Direta (direct sales to private hospitals, clinics, and home-care providers), Licitações (participation in public bidding processes for government healthcare facilities), and Compras (procurement support services). It serves more than 5,626 clients across Paraná, Santa Catarina, and additional Brazilian states under ANVISA regulatory standards.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 5,626+ clients served
+2 more records
Product overview1 text field

Promefarma is a pharmaceutical distribution company offering a unified portfolio of services and products. The core offerings include Venda Direta (direct sales with consulting), Licitações (public tender/bidding services), and Compras (procurement management). These services are supported by a comprehensive medications product line covering analgesics, anesthetics, antiallergics, antibacterials, antidiabetics, antihypertensives, anti-inflammatories, oncology drugs, controlled substances, injectables, biosimilars, high-cost medications, and other pharmaceutical products. The company serves both public (hospitals, clinics, government agencies) and private healthcare institutions across Brazil.

Product and service2 records
1Venda Direta (Direct Sales)
CategoryPharmaceutical Distribution Service
2Licitações (Public Bidding)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-13
Description

Clinic partnered with Promefarma during SIPAT 2026 to conduct influenza vaccination campaign for employees.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-13
Description

Healthcare operator that partnered with Promefarma for multiple employee health initiatives including SIPAT, disease prevention, and health campaigns.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-13
Description

Financial intelligence company that conducted financial sustainability presentations during SIPAT 2026.

Strategic tierMinorTypeOthersAnnounced on2026-04-02
Description

Christian association for social assistance that received Easter donations from Promefarma. Promefarma recognized as a partner company at ACRIDAS 41st anniversary event.

5Complexo de Saúde Pequeno Cotolengo
Strategic tierMinorTypeOthersAnnounced on2026-04-02
Description

Healthcare complex for people with disabilities that received Easter donations from Promefarma.

promefarma.com.br
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-17
Description

Pharmaceutical company that recognized Promefarma with a performance award in 2025 and hosted Blau Day event. Strong partnership marked by express results, collaboration, and joint growth with oncology product focus.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-11-10
Description

Cooperative financial institution that partnered with Promefarma for employee financial education training.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-04-11
Description

University whose nutrition students conducted food waste reduction workshop at Promefarma.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

Dental services provider that partnered with Promefarma for oral health presentations and free evaluations.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-10-23
Description

National Commercial Training Service that partnered for self-care and workplace harassment prevention training.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical manufacturer supplying medications through Promefarma's distribution network to healthcare institutions. Listed as a supplier partner on the Promefarma suppliers page.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Brazilian pharmaceutical company listed as a supplier partner providing medications for distribution.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Brazilian pharmaceutical laboratory listed as a supplier partner on Promefarma's supplier page.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Global pharmaceutical company listed as a supplier partner for medication distribution.

Strategic tierMinorTypeOthers
Description

Children's hospital in Paraná that receives donations from Promefarma's income.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Promefarma

Pharmaceutical Distributionpromefarma.com.br

Promefarma is a privately held Brazilian pharmaceutical distributor founded in 1989, headquartered in Curitiba, serving 5,626+ public and private healthcare institutions across 8 Brazilian states with a comprehensive medication portfolio through public bidding and direct sales channels.

What Promefarma does

Promefarma Produtos Farmacêuticos is a privately held Brazilian pharmaceutical distributor founded on December 12, 1989, and headquartered in Curitiba, Paraná. The company distributes a comprehensive medication portfolio—including analgesics, controlled substances, high-cost drugs, oncology products, biosimilars, injectables, and thrombolytics—to public and private healthcare institutions across at least eight Brazilian states (Paraná, Santa Catarina, Rio Grande do Sul, São Paulo, Rio de Janeiro, Minas Gerais, Mato Grosso, and Espírito Santo). Its go-to-market is sales-led and bifurcated: a dedicated public sector team handles licitações (public bidding processes) across federal, state, and municipal levels, while a separate direct sales force with supervisor accompaniment serves private hospitals, clinics, and home care providers. The company maintains roughly 100+ direct employees and serves 5,626+ active clients. Revenue is generated through transaction-fee-based medication distribution plus consulting services for product demonstrations and standardization visits. The business is founder-led by the Barotto brothers and currently directed by Élcio and Luciana, with no external investors or parent company involvement disclosed. Operational governance is supported by a compliance channel, ouvidoria, and SAC infrastructure, and the company has pursued ESG credentials—achieving the highest Selo Clima Paraná A certification in 2025—and received multiple governmental recognitions (ALEP "Paranaenses em Destaque" in 2026, Câmara Municipal de Curitiba congratulations in 2025). In early 2026, Promefarma reported a record historical monthly billing milestone for March.

Promefarma firmographics

Firmographics
Name
Promefarma
Legal name
Promefarma
Website
https://promefarma.com.br
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
51–100 employees
Short description
Promefarma is a privately held Brazilian pharmaceutical distributor founded in 1989, headquartered in Curitiba, serving 5,626+ public and private healthcare institutions across 8 Brazilian states with a comprehensive medication portfolio through public bidding and direct sales channels.
Ownership category
akta.pro rank

Promefarma industry classification

Industry
Product category
Pharmaceutical Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

  • Pharmaceutical distribution
  • Medication distribution
  • Healthcare procurement services
  • Public bidding services
  • Hospital medication supply

Where Promefarma is headquartered

Location

Headquarters

HQ city
Curitiba
HQ country
Brazil
HQ region
Latin America

Offices1 record

Markets served

Promefarma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Medication Distribution - Public Sector: Distribution of medications to government healthcare facilities through public bidding processes (licitações). The company has specialized professionals for all stages of bidding processes.
  2. Medication Distribution - Private Sector: Direct sales of medications to private hospitals, clinics, and home care institutions. Includes personalized negotiation and direct delivery.
  3. Direct Sales and Consulting: Consulting services for product demonstrations and standardization for healthcare institutions

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Promefarma product offering

Product offering

Core offering

Promefarma is a Brazilian pharmaceutical distributor headquartered in Curitiba, Paraná, that supplies a full line of medications—including controlled substances and high-cost drugs—to public and private healthcare institutions. The company operates three principal service lines: Venda Direta (direct sales to private hospitals, clinics, and home-care providers), Licitações (participation in public bidding processes for government healthcare facilities), and Compras (procurement support services). It serves more than 5,626 clients across Paraná, Santa Catarina, and additional Brazilian states under ANVISA regulatory standards.

Product overview

Promefarma is a pharmaceutical distribution company offering a unified portfolio of services and products. The core offerings include Venda Direta (direct sales with consulting), Licitações (public tender/bidding services), and Compras (procurement management). These services are supported by a comprehensive medications product line covering analgesics, anesthetics, antiallergics, antibacterials, antidiabetics, antihypertensives, anti-inflammatories, oncology drugs, controlled substances, injectables, biosimilars, high-cost medications, and other pharmaceutical products. The company serves both public (hospitals, clinics, government agencies) and private healthcare institutions across Brazil.

Differentiator

Problem solved

Functional benefit

Products and services

  • Venda Direta (Direct Sales)
  • Licitações (Public Bidding)

Quantifiable outcome

  • 5,626+ clients served
  • +2 more outcomes

Companies that use Promefarma

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Promefarma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Promefarma partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered minor and core.

  • Clínica VaccineminorStrategic or Co-development Partner · 13 April 2026Clinic partnered with Promefarma during SIPAT 2026 to conduct influenza vaccination campaign for employees.
  • Paraná ClínicascoreStrategic or Co-development Partner · 13 April 2026Healthcare operator that partnered with Promefarma for multiple employee health initiatives including SIPAT, disease prevention, and health campaigns.
  • GFX Inteligência FinanceiraminorStrategic or Co-development Partner · 13 April 2026Financial intelligence company that conducted financial sustainability presentations during SIPAT 2026.
  • ACRIDAS - Associação Cristã de Assistência SocialminorOthers · 2 April 2026Christian association for social assistance that received Easter donations from Promefarma. Promefarma recognized as a partner company at ACRIDAS 41st anniversary event.
  • Complexo de Saúde Pequeno CotolengominorOthers · 2 April 2026Healthcare complex for people with disabilities that received Easter donations from Promefarma.
  • Blau FarmacêuticacoreStrategic or Co-development Partner · 17 March 2026Pharmaceutical company that recognized Promefarma with a performance award in 2025 and hosted Blau Day event. Strong partnership marked by express results, collaboration, and joint growth with oncology product focus.
  • Sicredi Campos GeraisminorStrategic or Co-development Partner · 10 November 2025Cooperative financial institution that partnered with Promefarma for employee financial education training.
  • Universidade PositivominorStrategic or Co-development Partner · 11 April 2025University whose nutrition students conducted food waste reduction workshop at Promefarma.
  • DentalUniminorStrategic or Co-development Partner · 1 November 2024Dental services provider that partnered with Promefarma for oral health presentations and free evaluations.
  • SENACminorStrategic or Co-development Partner · 23 October 2024National Commercial Training Service that partnered for self-care and workplace harassment prevention training.
  • BayercoreChannel Partner/ Reseller/ DistributorPharmaceutical manufacturer supplying medications through Promefarma's distribution network to healthcare institutions. Listed as a supplier partner on the Promefarma suppliers page.
  • EurofarmacoreChannel Partner/ Reseller/ DistributorBrazilian pharmaceutical company listed as a supplier partner providing medications for distribution.
  • CristáliacoreChannel Partner/ Reseller/ DistributorBrazilian pharmaceutical laboratory listed as a supplier partner on Promefarma's supplier page.
  • CiplacoreChannel Partner/ Reseller/ DistributorGlobal pharmaceutical company listed as a supplier partner for medication distribution.
  • Hospital Pequeno PríncipeminorOthersChildren's hospital in Paraná that receives donations from Promefarma's income.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Promefarma competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Promefarma social profiles

Digital presence

Promefarma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Promefarma leadership team

Management profile

Number of profiles

Profiles2 records

Promefarma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Promefarma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Promefarma

What does Promefarma do?

Promefarma is a Brazilian pharmaceutical distributor headquartered in Curitiba, Paraná, that supplies a full line of medications—including controlled substances and high-cost drugs—to public and private healthcare institutions. The company operates three principal service lines: Venda Direta (direct sales to private hospitals, clinics, and home-care providers), Licitações (participation in public bidding processes for government healthcare facilities), and Compras (procurement support services). It serves more than 5,626 clients across Paraná, Santa Catarina, and additional Brazilian states under ANVISA regulatory standards.

Is Promefarma a public or private company?

Promefarma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Promefarma founded?

Promefarma was founded in 1989. It employs 51 to 100 people.

Where is Promefarma based?

Promefarma is headquartered in Curitiba, Brazil, in the Latin America region.

How does Promefarma make money?

Three revenue lines are on record. Medication Distribution - Public Sector is the primary driver. The others are medication Distribution - Private Sector and direct Sales and Consulting.

Does Promefarma have an API?

No public API is recorded for Promefarma.

What industry is Promefarma in?

Promefarma's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales